Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Kluender
Harold Kluender, Hartland, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090281079 | Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated With Angiogenesis - This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds and compositions for the prevention and/or treatment of hyper-proliferative disorders and diseases associated with angiogenesis. | 11-12-2009 |
| 20100063038 | Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis - This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. | 03-11-2010 |
Harold C.e. Kluender, Trumbull, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20080293696 | 2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents - A compound having the formula (1) | 11-27-2008 |
| 20090023753 | 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents - This invention relates to novel 1,3-thiazole-5-carboxamide compounds, pharmaceutical compositions containing such compounds, and the use of those compounds or compositions as cancer chemotherapeutic agents. | 01-22-2009 |
| 20100075958 | PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS - This invention relates to pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds and compositions for the prevention and/or treatment of hyper-proliferative disorders and diseases associated with angiogenesis. | 03-25-2010 |
Harold C. E. Kluender, Hartland, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20100179125 | SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS - This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. | 07-15-2010 |
Harold C. E. Kluender, Trumbull, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110263597 | SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY - Methods of treating a mammal having a condition characterized by abnormal angiogenesis or hyperpermiability processes using substituted pyridazines having angiogenesis inhibiting activity and the generalized structural formula | 10-27-2011 |
Keith Raymond Kluender, Madison, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20120134522 | System and Method for Selective Enhancement Of Speech Signals - A system and method for selectively enhancing an audio signal to make sounds, particularly speech sounds, more distinguishable. The system and method are designed to divide an input auditory signal into a plurality of spectral channels having associated unenhanced signals and perform enhancement processing on a first subset of the spectral channels and not perform enhancement processing on a second subset of the spectral channels. The enhancement processing is performed by determining an output gain for at least the first subset of spectral channels based on a time-varying history of energy of the unenhanced signals associated with each channel in the first subset of the spectral channels and applying the output gain for each of the first subset of the spectral channels to the unenhanced signals to form enhanced signals associated with each of the first subset of the spectral channels. The system and method are then designed to combine the plurality of enhanced signals associated with each of the first subset of the spectral channels and the unenhanced signals associated with each of the second subset of the spectral channels to form a selectively enhanced output auditory signal. | 05-31-2012 |